These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 19556449

  • 1. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
    Nishiyama K, Shintani Y, Hirai K, Yoshikubo S.
    J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
    [Abstract] [Full Text] [Related]

  • 2. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
    Audinot V, Bonnaud A, Grandcolas L, Rodriguez M, Nagel N, Galizzi JP, Balik A, Messager S, Hazlerigg DG, Barrett P, Delagrange P, Boutin JA.
    Biochem Pharmacol; 2008 May 15; 75(10):2007-19. PubMed ID: 18384758
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
    Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M.
    Neuropharmacology; 2005 Feb 15; 48(2):301-10. PubMed ID: 15695169
    [Abstract] [Full Text] [Related]

  • 4. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP, Davidson K, Kulla A, Sugden D.
    J Pineal Res; 2008 Sep 15; 45(2):125-32. PubMed ID: 18298466
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of M-II, the major human metabolite of ramelteon.
    Nishiyama K, Nishikawa H, Kato K, Miyamoto M, Tsukamoto T, Hirai K.
    Pharmacology; 2014 Sep 15; 93(3-4):197-201. PubMed ID: 24923230
    [Abstract] [Full Text] [Related]

  • 6. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
    Witt-Enderby PA, Dubocovich ML.
    Mol Pharmacol; 1996 Jul 15; 50(1):166-74. PubMed ID: 8700109
    [Abstract] [Full Text] [Related]

  • 7. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
    Koike T, Hoashi Y, Takai T, Nakayama M, Yukuhiro N, Ishikawa T, Hirai K, Uchikawa O.
    J Med Chem; 2011 May 12; 54(9):3436-44. PubMed ID: 21473625
    [Abstract] [Full Text] [Related]

  • 8. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.
    Roth T, Stubbs C, Walsh JK.
    Sleep; 2005 Mar 12; 28(3):303-7. PubMed ID: 16173650
    [Abstract] [Full Text] [Related]

  • 9. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
    Imbesi M, Uz T, Manev H.
    Neuroscience; 2008 Sep 09; 155(4):1160-4. PubMed ID: 18664376
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
    Markl C, Attia MI, Julius J, Sethi S, Witt-Enderby PA, Zlotos DP.
    Bioorg Med Chem; 2009 Jul 01; 17(13):4583-94. PubMed ID: 19473848
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
    Lucini V, Pannacci M, Scaglione F, Fraschini F, Rivara S, Mor M, Bordi F, Plazzi PV, Spadoni G, Bedini A, Piersanti G, Diamantini G, Tarzia G.
    J Med Chem; 2004 Aug 12; 47(17):4202-12. PubMed ID: 15293992
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
    Attia MI, Güclü D, Hertlein B, Julius J, Witt-Enderby PA, Zlotos DP.
    Org Biomol Chem; 2007 Jul 07; 5(13):2129-37. PubMed ID: 17581657
    [Abstract] [Full Text] [Related]

  • 15. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
    Markl C, Clafshenkel WP, Attia MI, Sethi S, Witt-Enderby PA, Zlotos DP.
    Arch Pharm (Weinheim); 2011 Oct 07; 344(10):666-74. PubMed ID: 21887801
    [Abstract] [Full Text] [Related]

  • 16. [A novel therapeutic drug: ramelteon].
    Miyamoto M.
    Nihon Rinsho; 2009 Aug 07; 67(8):1595-600. PubMed ID: 19768947
    [Abstract] [Full Text] [Related]

  • 17. The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor.
    Cogé F, Guenin SP, Fery I, Migaud M, Devavry S, Slugocki C, Legros C, Ouvry C, Cohen W, Renault N, Nosjean O, Malpaux B, Delagrange P, Boutin JA.
    Br J Pharmacol; 2009 Nov 07; 158(5):1248-62. PubMed ID: 19814723
    [Abstract] [Full Text] [Related]

  • 18. 7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.
    Faust R, Garratt PJ, Trujillo Pérez MA, Piccio VJ, Madsen C, Stenstrøm A, Frølund B, Davidson K, Teh MT, Sugden D.
    Bioorg Med Chem; 2007 Jul 01; 15(13):4543-51. PubMed ID: 17459711
    [Abstract] [Full Text] [Related]

  • 19. Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
    Mésangeau C, Fraise M, Delagrange P, Caignard DH, Boutin JA, Berthelot P, Yous S.
    Eur J Med Chem; 2011 May 01; 46(5):1835-40. PubMed ID: 21392858
    [Abstract] [Full Text] [Related]

  • 20. Recent advances in melatonin receptor ligands.
    Zlotos DP.
    Arch Pharm (Weinheim); 2005 Jun 01; 338(5-6):229-47. PubMed ID: 15952241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.